American Healthcare REIT, Inc. (AHR) Balance Sheet

The balance sheet is expanding rapidly, with total assets increasing from $4.6B in 2023Q4 to $5.6B in 2026Q1, a 21.7% compound annual growth rate. This growth is supported by a significant reduction in total debt, which fell from $3.0B to $1.5B over the same period, indicating a deleveraging trend. The equity base has more than doubled, from $1.3B to $3.5B, suggesting that the company is funding growth through retained earnings and equity issuance rather than incremental debt. This trajectory appears sustainable if the company can maintain its revenue momentum, but the thin margins warrant monitoring.

The portfolio's income-generating capacity appears strained, as NOI flipped to a negative $8.6M in 2026Q1 from a positive $108.2M a year earlier. This deterioration, despite a 20.4% revenue increase, indicates that operating costs—particularly labor—are consuming the incremental revenue. The company's heavy concentration in senior housing and integrated campuses, which have high variable costs, may be amplifying this pressure. Investors should monitor whether management can stabilize property-level margins through cost controls or rent increases, as the current trend suggests a potential decline in asset quality.

The company has made significant progress in deleveraging, with debt-to-equity improving from 2.07 in 2023Q4 to 0.44 in 2026Q1. Total debt decreased by $1.5B over the same period, while equity more than doubled, reflecting a combination of debt repayment and equity issuance. This shift reduces interest expense and financial risk, but the low absolute debt level may also indicate limited use of leverage to enhance returns. The maturity ladder and interest rate exposure are not disclosed in the provided data, but the reduced leverage suggests a more conservative capital structure that could support future growth.

The equity base has expanded dramatically, driven by retained earnings and likely secondary offerings, but return on equity remains weak at 0.7% in 2026Q1. This low ROE indicates that the substantial equity capital is not generating adequate net income, partly due to thin margins and high depreciation. The company's focus on senior housing and care, which requires significant operating expenses, may be diluting returns. Investors should watch whether management can improve operational efficiency to justify the equity expansion, as the current returns are below the cost of equity.

Liquidity has strengthened, with cash increasing to $119.4M, providing a cushion for operations and potential investments. However, the fixed charge coverage ratio is not directly provided, and the AFFO coverage of dividends at 1.12x in 2026Q1 suggests only a thin margin above the payout. The company's development pipeline and capital expenditure requirements, which averaged $30.1M per quarter, may strain liquidity if cash flows do not improve. The revolver capacity and covenant headroom are not disclosed, but the current cash position appears adequate for near-term obligations.

Forward visibility is limited by the lack of disclosed lease expiration schedules and development pipeline specifics. However, the negative NOI in 2026Q1 indicates that existing properties are not generating sufficient income, which may signal that lease renewals are at lower rents or occupancy is declining. The company's focus on senior housing, which has shorter lease terms and higher operational volatility, may reduce visibility compared to triple-net peers. Investors should seek additional disclosures on lease rollover and development timing to assess future cash flow stability.